Maja Bech Juul

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma

Tarec Christoffer El‐Galaly, Chan Y. Cheah, Mette Dahl Bendtsen et al. · European Journal of Cancer · 2018 · 136 citations · Full text

Medicine, Neurology, Oncology +11

Minimal Loss of Lifetime for Patients With Diffuse Large B-Cell Lymphoma in Remission and Event Free 24 Months After Treatment: A Danish Population-Based Study

Lasse Hjort Jakobsen, Martin Bøgsted, Peter de Nully Brown et al. · Journal of Clinical Oncology · 2017 · 101 citations

Medicine, Hematology, Oncology +9

The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy

Tarec Christoffer El‐Galaly, Diego Villa, Thomas Yssing Michaelsen et al. · European Journal of Cancer · 2017 · 96 citations · Full text

Medicine, Oncology, Radiology +13

Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study

Maja Bech Juul, Pernille Hammershoej Jensen, Henriette Engberg et al. · European Journal of Cancer · 2018 · 74 citations

Medicine, Hematology, Oncology +14

Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines

Steen Møller Hansen, Peter Enemark Lund, P Soegaard et al. · British Journal of Haematology · 2018 · 64 citations · Full text

Medicine, Cardiology, Oncology +17